R&D in pulverization technology and high-purity materials
First written in FY2016. 27 of 34 entries say "Restated". Latest entry: FY2026.
9 other companies' latest entry also says "Other".
- FY2026Increase in R&D ExpensesAnnual report
「Group-wide R&D expenses for the consolidated fiscal year were ¥13 million, all of which was incurred in the Company's Resources-related Business.」
R&D activities continued, and R&D expenses increased from ¥9 million in the previous fiscal year to ¥13 million. - FY2026-H1Increase in R&D ExpensesAnnual report
「The Group-wide R&D expenditure during the interim consolidated accounting period was ¥7 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
There were no material changes in the content of R&D activities, while R&D expenses increased from ¥4 million in the same period of the previous year to ¥7 million. - FY2025-H1RestatedAnnual report
「The Group-wide R&D expenditure during the interim consolidated accounting period was ¥4 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
There were no material changes in R&D activities, and R&D expenses for the interim consolidated accounting period were stated as ¥4 million. - FY2024Increase in R&D ExpensesAnnual report
「Group-wide R&D expenses for the consolidated fiscal year were ¥9 million, all of which was incurred in the Company's Resources-related Business.」
Research activities for high-purity new products using pulverization technology continued, and R&D expenses increased from ¥8 million in the previous fiscal year to ¥9 million. - FY2024-Q3RestatedAnnual report
「The Group-wide R&D expenditure during the third quarter cumulative consolidated period was ¥6 million. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
There were said to be no material changes in R&D activities, and R&D expenses for the third quarter cumulative period were ¥6 million. - FY2024-Q2RestatedAnnual report
「The Group-wide R&D expenditure during the second quarter cumulative consolidated period was ¥4 million. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the second quarter cumulative period were ¥4 million. - FY2024-Q1RestatedAnnual report
「The Group-wide R&D expenditure during the first quarter cumulative consolidated period was ¥2 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the first quarter cumulative period were stated as ¥2 million. - FY2023Decline in R&D SpendingAnnual report
「Group-wide R&D expenses for the consolidated fiscal year were ¥8 million, all of which was incurred in the Company's Resources-related Business.」
Research activities for high-purity new products using pulverization technology continued, but R&D expenses decreased from ¥16 million in the previous fiscal year to ¥8 million. - FY2023-Q3RestatedAnnual report
「The Group-wide R&D expenditure during the third quarter cumulative consolidated period was ¥6 million. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
There were said to be no material changes in R&D activities, and R&D expenses for the third quarter cumulative period were stated as ¥6 million. - FY2023-Q2RestatedAnnual report
「The Group-wide R&D expenditure during the second quarter cumulative consolidated period was ¥4 million. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
There were said to be no material changes in R&D activities, and R&D expenses for the second quarter cumulative period were ¥4 million. - FY2023-Q1RestatedAnnual report
「The Group-wide R&D expenditure during the first quarter cumulative consolidated period was ¥2 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the first quarter cumulative period were ¥2 million. - FY2022-Q3ReframedAnnual report
「We will focus on developing new products in the ultrafine powder category by leveraging our refining expertise.」
A specific focus was identified for the development of new products in the ultrafine powder category using refining expertise, as part of R&D in pulverization technology and high-purity materials. - FY2022-Q2RestatedAnnual report
「The group-wide amount spent on research and development activities during the cumulative second quarter was ¥8 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter.」
There were no material changes in R&D activities, and R&D expenses for the second quarter cumulative period were stated as ¥8 million. - FY2022-Q1RestatedAnnual report
「The Group-wide R&D expenditure during the first quarter cumulative consolidated period was ¥4 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the first quarter cumulative period were stated as ¥4 million. - FY2021Increase in R&D ExpensesAnnual report
「The Group (the Company and its consolidated subsidiaries) is pursuing research activities, including the development of high-purity new products using its pulverization technology. Group-wide R&D expenses for the consolidated fiscal year were ¥16 million, all of which was incurred in the Company's Resources-related Business.」
Research activities for high-purity new products using pulverization technology continued, and R&D expenses increased from ¥11 million in the previous fiscal year to ¥16 million. - FY2021-Q3RestatedAnnual report
「The group-wide amount spent on research and development activities during the cumulative third quarter was ¥11 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter.」
There were no material changes in R&D activities, and R&D expenses for the third quarter cumulative period were stated as ¥11 million. - FY2021-Q2RestatedAnnual report
「The Group-wide R&D expenditure during the second quarter cumulative consolidated period was ¥7 million. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the second quarter cumulative period were stated as ¥7 million. - FY2021-Q1RestatedAnnual report
「The Group-wide R&D expenditure during the first quarter cumulative consolidated period was ¥3 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the first quarter cumulative period were stated as ¥3 million. - FY2020-Q3RestatedAnnual report
「The Group-wide R&D expenditure during the third quarter cumulative consolidated period was ¥8 million. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses were stated as ¥8 million. - FY2020-Q2RestatedAnnual report
「The Group-wide R&D expenditure during the second quarter cumulative consolidated period was ¥5 million. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses were stated as ¥5 million. - FY2020-Q1RestatedAnnual report
「The Group-wide R&D expenditure during the first quarter cumulative consolidated period was ¥2 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the first quarter cumulative period were stated as ¥2 million. - FY2019RestatedAnnual report
「The Group (the Company and its consolidated subsidiaries) is pursuing research activities, including the development of high-purity new products using its pulverization technology. Group-wide R&D expenses for the consolidated fiscal year were ¥11 million, all of which was incurred in the Company's Resources-related Business.」
R&D activities continued, but R&D expenses decreased from ¥15 million in the previous fiscal year to ¥11 million. - FY2019-Q3RestatedAnnual report
「The Group-wide R&D expenditure during the third quarter cumulative consolidated period was ¥8 million. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the third quarter cumulative period were stated as ¥8 million. - FY2019-Q2RestatedAnnual report
「The Group-wide R&D expenditure during the second quarter cumulative consolidated period was ¥5 million. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the second quarter cumulative period were stated as ¥5 million. - FY2019-Q1RestatedAnnual report
「The Group-wide R&D expenditure during the first quarter cumulative consolidated period was ¥2 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the first quarter cumulative period were stated as ¥2 million. - FY2018RestatedAnnual report
「The Group (the Company and its consolidated subsidiaries) is pursuing research activities, including the development of high-purity new products using its pulverization technology. Group-wide R&D expenses for the consolidated fiscal year were ¥15 million, all of which was incurred in the Company's Resources-related Business.」
Research activities for high-purity new products using pulverization technology continued, and R&D expenses were stated as ¥15 million. - FY2018-Q3RestatedAnnual report
「The Group-wide R&D expenditure during the third quarter cumulative consolidated period was ¥12 million. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
There were said to be no material changes in R&D activities, and R&D expenses for the third quarter cumulative period were ¥12 million. - FY2018-Q2RestatedAnnual report
「The group-wide amount spent on research and development activities during the cumulative second quarter was ¥10 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter.」
There were said to be no material changes in R&D activities, and cumulative R&D expenses for the quarter were ¥10 million. - FY2018-Q1RestatedAnnual report
「The Group's total research and development activities during the three-month period ended the first quarter amounted to ¥5 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended the first quarter.」
There were said to be no material changes in R&D activities, and R&D expenses were stated as ¥5 million. - FY2017RestatedAnnual report
「The Group (the Company and its consolidated subsidiaries) is pursuing research activities, including the development of high-purity new products using its pulverization technology.」
R&D activities are continuing, with current-period R&D expenses of ¥14 million allocated to research into environmental materials based on in-house materials and the purification of refined silica powder. - FY2017-Q3RestatedAnnual report
「The Group-wide R&D expenditure during the third quarter cumulative consolidated period was ¥9 million. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the third quarter cumulative period were ¥9 million. - FY2017-Q2RestatedAnnual report
「The Group-wide R&D expenditure during the second quarter cumulative consolidated period was ¥4 million. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the first half cumulative period were stated as ¥4 million. - FY2017-Q1RestatedAnnual report
「The Group-wide R&D expenditure during the first quarter cumulative consolidated period was ¥2 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
There were no material changes in R&D activities, and quarterly R&D expenses were stated as ¥2 million. - FY2016First statedAnnual report
「The Group (the Company and its consolidated subsidiaries) is pursuing research activities, including the development of high-purity new products using its pulverization technology.」
R&D expenses were ¥14 million, with research conducted in the Resources-related Business into environmental materials and the purification of refined silica powder.